Skip to content
SEKISUI XenoTech DD Blog Logo

In Vivo ADME Expertise Providing Cost Savings

ADME studies are a vital part of the drug development process, and therefore, deciding where and how to perform these studies are choices that should not be taken lightly. Of course, you can perform these assays in-house if you have an established lab with all the experience, proper protocols and experimental controls required to meet FDA requirements, but those are capabilities not easily obtained or maintained. Increasingly, drug development studies are being outsourced to CROs that adhere to the same strict standards as regulatory pharmaceutical programs without the cost burdens of maintaining an in-house laboratory. This outsourcing dynamic is becoming the testing paradigm of choice when cost reduction is desired without sacrificing quality and integrity. For over 50 years, SEKISUI has been the most trusted contract laboratory for many pharmaceutical companies.

SEKISUI performs animal studies under the strictest of quality control standards and accreditation requirements. Our Tokai, Japan lab has gained worldwide renown for their expertise performing in vivo ADME studies. Known especially for studies using radiolabeled compounds, we perform PK studiesQWBA distribution studiesmetabolite ID and profilingmass balance and biliary excretion studies in our state-of-the-art AALAC accredited laboratory.

Over 10 years ago, SEKISUI and the expertise of the Tokai Drug Development Solutions Center merged with XenoTech in Kansas City, KS. This adjoining was a marriage made from similar values and the shared importance of quality, experience and expertise. If you haven’t worked with our Tokai laboratory, we don’t want you to miss out on the incredible value of this famous laboratory. So we have lowered pricing on many of our in vivo services so you can experience the same quality studies they have always offered but at a reduced price.

Find out more about performing your in vivo ADME studies with us, or get in touch with your local services representative so you too can gain from this value.

Learn more about:

About the Authors

Scott Hickman has managed the customer experience for innovative life science companies for over 25 years and currently serves as the Director of Global Marketing for SEKISUI XenoTech, joining in 2018. Scott received a BA from Randolph-Macon College and his MBA from George Washington University.

Subscribe to our Newsletter

Stay up to date with our news, events and research

In vitro pipette test article treatment
005 International Messaging Created with Sketch.

Do you have a question or a request for upcoming blog content?

We love to get your feedback

A scientist utlilizing a microplate